Helus Pharma Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
10.69
+0.14 (1.33%)
At close: Oct 19, 2026, 4:00 PM EDT
10.76
+0.07 (0.68%)
After-hours: Oct 19, 2026, 4:40 PM EDT
Helus Pharma Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
100
Market Cap
781.01M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | - | - | - |
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ardelyx | 450.89M |
| Geron | 204.56M |
| Apnimed | 115.12M |
| Kura Oncology | 77.23M |
| Alumis | 7.40M |
| Inventiva | 2.81M |
HELP News
- 4 days ago - Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors - GlobeNewsWire
- 11 days ago - Helus Pharma to Host Investor Presentation on October 21, 2026 - GlobeNewsWire
- 12 days ago - Helus Pharma Slides: Corporate presentation - Filings
- 18 days ago - Helus Pharma announces completion of legal name change - TheFly
- 18 days ago - Helus Pharma Announces Completion of Legal Name Change - GlobeNewsWire
- 26 days ago - Helus Pharma Transcript: TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit - Transcripts
- 27 days ago - Helus Pharma Announces Results of Annual and Special Meeting of Shareholders and Effective Date for Legal Name Change - GlobeNewsWire
- 27 days ago - Helus Pharma Transcript: AGM 2026 - Transcripts